Agelasine D Suppresses RANKL-Induced Osteoclastogenesis via Down-Regulation of c-Fos, NFATc1 and NF-κB
- Supplementary File 1:
Supplementary (PDF, 53 KiB)
Kang, M.R.; Jo, S.A.; Yoon, Y.D.; Park, K.H.; Oh, S.J.; Yun, J.; Lee, C.W.; Nam, K.-H.; Kim, Y.; Han, S.-B.; Yu, J.; Rho, J.; Kang, J.S. Agelasine D Suppresses RANKL-Induced Osteoclastogenesis via Down-Regulation of c-Fos, NFATc1 and NF-κB. Mar. Drugs 2014, 12, 5643-5656.
Kang MR, Jo SA, Yoon YD, Park KH, Oh SJ, Yun J, Lee CW, Nam K-H, Kim Y, Han S-B, Yu J, Rho J, Kang JS. Agelasine D Suppresses RANKL-Induced Osteoclastogenesis via Down-Regulation of c-Fos, NFATc1 and NF-κB. Marine Drugs. 2014; 12(11):5643-5656.
Chicago/Turabian StyleKang, Moo R.; Jo, Sun A.; Yoon, Yeo D.; Park, Ki H.; Oh, Soo J.; Yun, Jieun; Lee, Chang W.; Nam, Ki-Hoan; Kim, Youngsoo; Han, Sang-Bae; Yu, Jiyeon; Rho, Jaerang; Kang, Jong S. 2014. "Agelasine D Suppresses RANKL-Induced Osteoclastogenesis via Down-Regulation of c-Fos, NFATc1 and NF-κB" Mar. Drugs 12, no. 11: 5643-5656.